Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Shuo Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3718-2034; OpenAlex author ID A5100703220. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Elevated SAMD3 expression in T cells predicts improved survival in pancreatic ductal adenocarcinoma patients. Co-author DOI 10.1007/s00262-025-03948-x↗
  2. Angiogenesis in pancreatic cancer: current research status and clinical implications. Co-author DOI 10.1007/s10456-018-9645-2↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lingyi Fu · 1 shared paper, 2025 · strength 0.27
  2. Bokang Cui · 1 shared paper, 2025 · strength 0.27
  3. Enliang Zhou · 1 shared paper, 2025 · strength 0.27
  4. Wen-Quan Wang · 1 shared paper, 2019 · strength 0.08
  5. Zi-Hao Qi · 1 shared paper, 2019 · strength 0.08
  6. He-Li Gao · 1 shared paper, 2019 · strength 0.08
  7. Shi-Rong Zhang · 1 shared paper, 2019 · strength 0.08
  8. Hao Li · 1 shared paper, 2019 · strength 0.08
  9. Wei Jin · 1 shared paper, 2019 · strength 0.08
  10. Huaxiang Xu · 1 shared paper, 2019 · strength 0.08
  11. Liang Liu · 1 shared paper, 2019 · strength 0.08
  12. Jin-Zhi Xu · 1 shared paper, 2019 · strength 0.08
  13. Chuntao Wu · 1 shared paper, 2019 · strength 0.08
  14. Xianjun Yu · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.